Kimia Biosciences Ltd.
Snapshot View

51.50 +3.40 ▲7.1%

05 August 2021, 04:00:00 P.M.
Volume: 24,293

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kimiabiosciences.com
Financial Indicators
Market Cap 244.37 Cr.
Earnings per share (EPS) 1.08 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 47.88 Trailing Twelve Months Ending 2021-03
Industry PE 32.75 Trailing Twelve Months Ending 2021-03
Book Value / Share 3.90 Trailing Twelve Months Ending 2021-03
Price to Book Value 13.25 Calculated using Price: 51.65
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 4.73 Cr. 47,312,741 Shares
FaceValue 1
Company Profile

Laurel Organics is a Public limited company, which was incorporated in September 1993 in district Gurgaon, Haryana (India), situated at about 20 miles distance from Indira Gandhi International Airport, New Delhi. The state of the art manufacturing facility is situated in over 5.8 acres of land. Kimia Biosciences acquired Laurel Organics in the year 2016 and therefore, became a Promoter of the company.

Business area of the company:

The company is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.

Products

  • Benfotiamine 
  • Cilnidipine 
  • Gliclazide 
  • Levosulpride 
  • Rosuvastatin Calcium 
  • Tranexamic Acid 
  • Benidipine 
  • Teneligliptin Hydrate Hydrobromide 
  • Acotiamide 
  • Citicoline Sodium 
  • Luliconazole 
  • Deflazacort 
  • Voglibose 
  • Oxaceprol 
  • Ursodeoxycholic Acid 
  • Bacitracin Zinc 
  • Isotretinoin 
  • Tretinoin



Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+7.07%
1 Week
+8.65%
1 Month
+5.64%
3 Month
+14.83%
6 Month
+10.40%
1 Year
+73.40%
2 Year
+106.00%
5 Year
+791.00%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 33.34 62.28 -34.59 -166.09 243.83 16.47
Return on Capital Employed (%) 22.30 43.72 -23.86 -135.77 -216.82 -18.30 11.83 16.94 8.94
Return on Assets (%) 6.58 20.12 -13.60 -33.62 -92.83 -11.72 4.76 6.24 1.83

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 1 3 2 0 -4 -5 2 6 13
Non Curr. Liab. 2 1 1 1 7 9 25 29 34
Curr. Liab. 3 2 2 3 1 7 31 30 39
Minority Int.
Equity & Liab. 7 6 6 5 4 12 58 65 86
Non Curr. Assets 4 4 4 4 4 10 15 18 25
Curr. Assets 2 2 1 1 1 2 43 48 61
Misc. Exp. not W/O
Total Assets 7 6 6 5 4 12 58 65 86

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 9 12 6 2 0 1 76 94 106
Other Income 0 0 0 1 0 1 1 1 1
Total Income 9 12 7 2 0 2 77 95 107
Total Expenditure -8 -10 -7 -4 -4 -2 -74 -88 -102
PBIDT 1 2 0 -1 -3 0 3 7 5
Interest 0 0 0 0 -1 0 -1 -2 -3
Depreciation 0 0 0 0 0 0 -1 -1 -2
Taxation 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 1 -1 -2 -4 -1 2 4 1

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 2 1 1 0 -6 -1 -7 -3 0
Cash Fr. Inv. -1 -1 0 0 0 -6 -2 -2 -9
Cash Fr. Finan. -1 -1 0 0 6 7 10 4 8
Net Change 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 1 0 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 72.61 70.93 70.93 74.42 74.94 74.94 74.94 74.94 74.94
Public 27.39 29.07 29.07 25.58 25.06 25.06 25.06 25.06 25.06
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Wed, 04 Aug 2021
Certificate Of Recognition Of One Star Export House
We are pleased to inform that the Company has been granted Status of One Star Export House in accordance with the provisions of the Foreign Trade Policy 2015-2020 by Directorate General of Foreign Trade Ministry of Commerce & Industry for the period of 5 years;

The said intimation is being given under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Kindly take the above information on your records.
Tue, 03 Aug 2021
Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015 -Intimation Of Meeting Of Board Of Directors
Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2021 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the meeting of Board of Directors of the Company is scheduled to be held on Thursday August 12 2021 at 3.00 p.m. at Corporate Office of the Company viz. 974 9th Floor Aggarwal Millenium Tower-II Netaji Subhash Place Pitampura New Delhi-110034 inter alia to consider & approve the Un-Audited Financial Results (Standalone) for the first quarter ended on June 30th 2021. the Trading Window for dealing in the Equity Shares of the Company by Designated Persons (and their immediate relatives) has already been closed w.e.f. 1st July 2021 up to the completion of 48 hours after the declaration of unaudited Financial Results for the 1st quarter ended 30th June 2021 to the Stock Exchange.
Kindly take the above information on your record.
Tue, 13 Jul 2021
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

In compliance with Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to bring to your kind notice that we have received the Information regarding Issue of Duplicate Share certificates from shareholder as detailed below;
Sr. No. Folio No. Name No. of Shares Certificate No. Distinctive No.
1. 14235 ARUN K GUPTA 1400 10575 2933101 to 2934500
2. 14055 ARUN K GUPTA 1000 10431 2874801 to 2875800

Duplicate share certificate will be issued after completing necessary formalities.
Please take the same on your record.

Technical Scans View Details

Thu, 05 Aug 2021
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week High Close Crossing Last Week High
Closing Above Previous High Closing Above Previous High

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 188,551.74 785.85 +0.0%
Divi's Laboratories Ltd. 130,702.13 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. 79,575.04 4,783.30 +0.2%
Cipla Ltd. 76,243.85 945.20 +0.6%
Cadila Healthcare Ltd. 59,868.47 584.80 -0.5%
Piramal Enterprises Ltd. 59,065.41 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. 58,599.44 4,075.50 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 31.41 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 65.87 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.80 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 31.70 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 28.06 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 44.33 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 389.73 4,075.50 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 3.94 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 14.06 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.45 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 4.17 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 4.61 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1.73 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.75 4,075.50 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 0.10 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,075.50 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 14.13 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,075.50 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 32.07 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 17.85 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 10.03 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,075.50 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 19,159.59 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,075.50 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 2,401.30 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,075.50 +0.2%